What the six lenses say about BIOCON — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How BIOCON’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +1.3pp | -2.7pp | -5.9pp | +16.1pp | +13.0pp | +13.9pp |
Nifty 500 Broad-market baseline | +0.9pp | -2.8pp | -6.5pp | +12.5pp | +8.0pp | +10.0pp |
Sector Own-sector index | — | — | -8.9pp | +0.0pp | -6.4pp | -7.8pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
BIOCON daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
BIOCON ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 3,433 | 3,590 | 3,821 | 4,417 | 3,942 | 4,296 | 4,173 | 4,517 |
| ↳ change QoQ | — | +4.6% | +6.4% | +15.6% | -10.8% | +9.0% | -2.9% | +8.2% |
| EBITDA (₹cr) | 1,787 | 744 | 805 | 1,078 | 749 | 835 | 834 | 1,020 |
| EBITDA margin | 52.0% | 20.7% | 21.1% | 24.4% | 19.0% | 19.4% | 20.0% | 22.6% |
| PAT (₹cr) | 862 | 27 | 81 | 459 | 89 | 133 | -52 | 199 |
| ↳ change QoQ | — | -96.9% | +199.3% | +466.0% | -80.6% | +49.4% | -139.1% | +482.7% |
| Net margin | 25.1% | 0.8% | 2.1% | 10.4% | 2.3% | 3.1% | -1.3% | 4.4% |
| EPS (₹) | 5.51 | -0.13 | 0.21 | 2.87 | 0.23 | 0.63 | 1.08 | 0.78 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding BIOCON (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| SBI Large & Midcap Reg Gr | 2.05% | 40,850 | |
| SBI ELSS Tax Saver Reg Gr | 0.54% | 31,839 | |
| Kotak Large & Midcap Reg Gr | 1.74% | 31,263 | |
| SBI Midcap Reg Gr | 2.70% | 24,127 | |
| SBI Multicap Reg Gr | 1.95% | 23,693 | |
| SBI Flexicap Reg Gr | 1.29% | 22,685 | |
| Bandhan Large & Mid Cap Gr | 0.66% | 17,461 | |
| Franklin India Mid Cap Gr | 2.18% | 12,231 | |
| Nippon India Pharma Bns | 0.68% | 9,044 | |
| Nippon India Pharma Gr | 0.68% | 9,044 |
ETFs holding BIOCON (10)